Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers

Clinical trial NCT06188624 · RECRUITING

Trial details

NCT number: NCT06188624
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2024-02-01
Primary completion: 2026-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.